A. Williams et al., Compromised antioxidant status and persistent oxidative stress in lung transplant recipients, FREE RAD RE, 30(5), 1999, pp. 383-393
Oxidative stress may be a key feature, and hence important determinant, of
tissue injury and allograft rejection in lung transplant recipients. To inv
estigate this, we determined the antioxidant status (urate, ascorbate, thio
ls and a-tocopherol) and lipid peroxidation status (malondialdehyde) in bro
nchoalveolar lavage (BAL) fluid and blood serum of 19 consecutive lung tran
splant recipients 2 weeks and 1, 2, 3, 6, and 12 months post-surgery. BAL f
luid and blood samples from 23 control subjects and blood from 8 patients t
wo days before transplantation were obtained for comparison. Before surgery
, the antioxidant status of patients was poor as serum ascorbate and total
thiol concentrations were significantly (p < 0.05) lower than control subje
cts. Two weeks post-surgery, ascorbate and total thiol concentrations were
still low and urate concentrations had fallen compared to control subjects
(p < 0.01). At this time, BAL fluid urate concentration was higher (p < 0.0
1), ascorbate concentration was lower (p < 0.01) and reduced glutathione co
ncentrations were similar to control subjects. MDA, a product of lipid pero
xidation, was higher (p < 0.01) in both BAL fluid and serum obtained from t
ransplant patients compared to control subjects. During the first 12 months
post-surgery, little improvement in antioxidant status or extent of lipid
peroxidation was seen in transplant recipients. Regression analysis indicat
ed no difference in serum or BAL fluid antioxidant status in patients with
acute rejection compared to those without. In conclusion, lung transplant r
ecipients have a compromised antioxidant status before surgery and it remai
ns poor for at least the first year following the operation. In addition, t
hese patients have elevated MDA concentrations in both their lung lining fl
uid and blood over most of this time. Oxidative stress is not, however, a s
ufficiently sensitive endpoint to predict tissue rejection in this group.